We hypothesize these features reflect the preclinical change of the peritoneal microenvironment, the proliferation of the free cancer cells in the area of ‘milky-spots’ [17], and the angiogenesis driven by vascular endothelial growth factor in the peritoneum, which may explain the heterogeneous change of peritoneal area. The gene discussed is VEGFA; the disease is cancer.